Bret Jensen

See key challenges in commercial real estate as rising debt and delinquencies threaten economic stability. Click for my look at how CRE is affecting the economy.

The housing market still has plenty of pain left to feel. Click here for more information on the U.S. Economy.

Crinetics Pharmaceuticals' stock has surged after FDA approval of Palsonify for acromegaly. Click here to read the latest analysis on CRNX stock now.

Biotech and biopharma M&A activity has surged in recent weeks, sparking a strong sector rally and renewed optimism. Learn why stocks like AVDL look attractive.

Bristol-Myers Squibb Company has had a recent 30% stock decline amid concerns over patent expirations. Click here to read why BMY stock is a Hold.

The biotech sector has underperformed the market for many years now, but there are reasons to be optimistic. Click here for more on Quick Picks & Lists.

I-Mab Biopharma surged on promising givastomig results in gastric cancer. Click for my updated look at IMAB stock and why I am remaining neutral.

Markets plunged on Friday due to an unexpected escalation on the trade front between the U.S. and China, the two largest economies in the world. Read what investors need to know.

The U.S. residential real estate market, the world's largest asset class, is showing notable warning signs of trouble and serious stress. Read the full analysis now.

The market is currently in an overbought condition and is being driven primarily by a surge of tech spending. Click here for more information on U.S. Economy.